NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/05/2023
Back to search
Official data from USPTO
SUPERDONOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
09/05/2023
Trademark type
Combined
Nice classes
5
Filing date
12/30/2021
Registration date
09/05/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/05/2023
Last transaction
09/05/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Nes Ziyyona, IL
Examiner
SHOOR, AMIT
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "SUPERDONOR" in stylized font, with a dot to the left side of the initial "S" and also in the center of the second "O" of DONOR; the first "O" of DONOR is in a shape of a lens of a magnifying glass.
Holders and representatives
Holders
MYBIOTICS PHARMA LTD
Representatives
Yael Rouach Cabilly CABILLY & CO.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietary supplements; food supplements; nutritional supplements; dietary and nutritional supplements; dietary food supplemental drinks; dietary food supplements; dietary supplement drink mixes in the nature of vitamin and mineral beverages; dietary supplements for animals; dietary supplements for human consumption; dietary supplements with a cosmetic effect; powdered food supplements; powdered nutritional supplements; probiotic supplements; probiotic dietary supplements; probiotic preparations for medical use; sedatives; antifungal medication in the nature of antifungal preparations; medicines for alleviating constipation; pharmaceutical preparations for treating allergies; pharmaceutical preparations for the treatment of hormonal disorders; medicines for treating intestinal disorders; preparations for treating colds; burn relief medication; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical antitussive-cold preparations; non-prescription medicinesmedicinal preparations in the nature of pillstabletscapsulescapletsliquid dropssachetsoral liquidssuspensionsliquidssemi-solidscreamssyrupsointmentslotionsgelsspraysemulationsoilspessariessuppositoriesgranules and films for the treatment of cardiovascular disordersantibiotic associated diarrheagastrointestinal disordersneurological disordersophthalmological disordersneurodegenerative disorderscognitive impairmentdamaged skin and tissuepulmonary disordersfor supporting oncology treatmentsfor the prevention and treatment of allergiesfor the prevention and treatment of bacterial vaginosis and vaginal related women health disordersfor the prevention and treatment of urogenital related health disordersfor alleviating constipationfor the prevention and treatment of dysbiosisfor enrichment of beneficial bacteria; medicines for dental purposes; medicines for veterinary purposes namelyanti-infective products for veterinary useveterinary pharmaceutical preparations and substances for the treatment of cardiovascular disordersantibiotic associated diarrheagastrointestinal disordersneurological disordersophthalmological disordersneurodegenerative disorderscognitive impairmentdamaged skin and tissuepulmonary disordersfor supporting oncology treatmentsfor the prevention and treatment of allergiesfor the prevention and treatment of vaginal related health disordersfor the prevention and treatment of urogenital related health disordersfor alleviating constipationfor the prevention and treatment of dysbiosisfor enrichment of beneficial bacteria; pain relief medication; decongestant capsules; herbal medicinesmedicinal herbal preparationsherbal pharmaceutical preparations and herbal substances for the treatment of cardiovascular disordersantibiotic associated diarrheagastrointestinal disordersneurological disordersophthalmological disordersneurodegenerative disorderscognitive impairmentdamaged skin and tissuepulmonary disordersfor supporting oncology treatmentsfor the prevention and treatment of allergiesfor the prevention and treatment of vaginal related health disordersfor the prevention and treatment of urogenital related health disordersfor alleviating constipationfor the prevention and treatment of dysbiosisfor enrichment of beneficial bacteria; antihypertensives; antitussives; diarrhea medication; antiflatulants ; antiemetics; antivirals; pharmaceutical preparations for the treatment of allergic rhinitis; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; medicines for treating gastrointestinal diseases
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/20/2023
PUBO
PUBLISHED FOR OPPOSITION
06/20/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/31/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
05/15/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
05/12/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/09/2023
DOCK
ASSIGNED TO EXAMINER
02/21/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/11/2022
GNRT
NON-FINAL ACTION E-MAILED
10/11/2022
CNRT
NON-FINAL ACTION WRITTEN
10/11/2022
DOCK
ASSIGNED TO EXAMINER
10/05/2022
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/06/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/05/2022
NWAP
NEW APPLICATION ENTERED
01/03/2022
Continuous trademark protection
Get notified about every new filing that threatens SUPERDONOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.